Additionally, its inhibitory effect on obesity-induced inflammation operates through the activation of the nuclear factor erythroid 2-related factor–heme oxygenase-1 (Nrf2-HO-1) signaling pathway, suggesting its crucial role in the anti-inflammatory effects of brassinin [33]. Here, HMOX1 is linked to obesity due to melanocortin 4 receptor deficiency.